List of Tables
Table 1. Immune Thrombocytopenic Purpura Therapeutics Market Opportunities & Trends in Global Market
Table 2. Immune Thrombocytopenic Purpura Therapeutics Market Drivers in Global Market
Table 3. Immune Thrombocytopenic Purpura Therapeutics Market Restraints in Global Market
Table 4. Key Players of Immune Thrombocytopenic Purpura Therapeutics in Global Market
Table 5. Top Immune Thrombocytopenic Purpura Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Immune Thrombocytopenic Purpura Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Immune Thrombocytopenic Purpura Therapeutics Product Type
Table 9. List of Global Tier 1 Immune Thrombocytopenic Purpura Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Thrombocytopenic Purpura Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type – Immune Thrombocytopenic Purpura Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type – Immune Thrombocytopenic Purpura Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application – Immune Thrombocytopenic Purpura Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application – Immune Thrombocytopenic Purpura Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region – Global Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region – Global Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country – North America Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country – North America Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country – Europe Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country – Europe Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region – Asia Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region – Asia Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country – South America Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country – South America Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country – Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country – Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Inc. Corporate Summary
Table 31. Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 32. Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Baxalta Incorporated Corporate Summary
Table 34. Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 35. Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim GmbH Corporate Summary
Table 37. Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 38. Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Company Corporate Summary
Table 40. Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 41. Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eisai Corporate Summary
Table 43. Eisai Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 44. Eisai Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Hansa Medical AB Corporate Summary
Table 46. Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 47. Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Immunomedics, Inc. Corporate Summary
Table 49. Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 50. Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Intas Pharmaceuticals Ltd. Corporate Summary
Table 52. Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 53. Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
Table 55. Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 56. Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Merck & Co., Inc. Corporate Summary
Table 58. Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 59. Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Momenta Pharmaceuticals, Inc. Corporate Summary
Table 61. Momenta Pharmaceuticals, Inc. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 62. Momenta Pharmaceuticals, Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Novartis AG Corporate Summary
Table 64. Novartis AG Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 65. Novartis AG Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Pfizer Inc. Corporate Summary
Table 67. Pfizer Inc. Immune Thrombocytopenic Purpura Therapeutics Product Offerings
Table 68. Pfizer Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Immune Thrombocytopenic Purpura Therapeutics Segment by Type in 2021
Figure 2. Immune Thrombocytopenic Purpura Therapeutics Segment by Application in 2021
Figure 3. Global Immune Thrombocytopenic Purpura Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immune Thrombocytopenic Purpura Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immune Thrombocytopenic Purpura Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune Thrombocytopenic Purpura Therapeutics Revenue in 2021
Figure 8. By Type – Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application – Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region – Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country – North America Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country – Europe Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region – Asia Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country – South America Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country – Middle East & Africa Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Immune Thrombocytopenic Purpura Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eisai Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Momenta Pharmaceuticals, Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novartis AG Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Pfizer Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
